Alerts will be sent to your verified email
Verify EmailSGRL
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Shree Ganesh Remedies produces and supplies drug intermediates and specialty chemicals for the pharmaceutical industry. Their product range includes items related to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers, and anti-viral drugs.
Shree Ganesh Remed. major competitors are NGL Fine-Chem, AMI Organics, Kopran, Themis Medicare, Nectar Lifesciences, SMS Lifesciences, Hester Biosciences.
Market Cap of Shree Ganesh Remed. is ₹1,018 Crs.
While the median market cap of its peers are ₹957 Crs.
Shree Ganesh Remed. seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
Earnings Release | Mar Jun Sep Dec | Mar Jun Sep Dec | ||||||||||||||||
Investor Presentation | Jun Sep Dec | Mar | Mar | |||||||||||||||
Conference Call | Sep | |||||||||||||||||
Conference Call SummaryCon Call Summary
Powered by Gemini
|